Takeshi F Takahashi (Takeshi Takahashi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Topics

Locally Advanced

Radical Prostatectomy

Clinical Practice

Top Venues

BJU international

World journal of urology

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Takeshi F Takahashi
Urologists and pathologists in prostate cancer screening. Virchows Archiv : an international journal of pathology (2024)
Takeshi F Takahashi
Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening. World journal of urology 42 (1) (2024)
Takeshi F Takahashi
Endpoint and control group in prostate cancer screening research: public health basics. BJU international 134 (2) (2024)
Takeshi F Takahashi
Prostate cancer screening and Gleason score: empirical clinical practice. Virchows Archiv : an international journal of pathology (2024)
Takeshi F Takahashi
Active surveillance in all cases of screen-detected prostate cancer. BJU international 134 (1) (2024)
Takeshi F Takahashi
Determining the clinical significance of pathological findings in prostate cancer. Virchows Archiv : an international journal of pathology (2024)
Takeshi F Takahashi
Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening. World journal of urology 42 (1) (2024)
Takeshi F Takahashi
Observational study on screen-detected prostate cancer: case series of empirical clinical practice. BJU international (2024)
Takeshi F Takahashi
Cost-effectiveness analysis of prostate cancer screening and MRI. World journal of urology 42 (1) (2024)
Takeshi F Takahashi
Cost-effectiveness analysis of prostate cancer screening and MRI. World journal of urology 42 (1) (2024)
Takeshi F Takahashi
Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer. Radiology 312 (3) (2024)
Takeshi F Takahashi
Active surveillance in all cases of screen-detected prostate cancer. BJU international (2024)
Takeshi F Takahashi
Endpoint and control group in prostate cancer screening research: public health basics. BJU international (2024)
Takeshi F Takahashi
Two conflicting guidelines on prostate specific antigen screening in Japan. Japanese journal of clinical oncology 53 (3) (2023)
Takeshi F Takahashi
Guidelines by Urologists and Public Health Professionals: Different Perspectives on Prostate Specific Antigen Screening. Journal of cancer education : the official journal of the American Association for Cancer Education (2023)
Takeshi F Takahashi
Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials. Radiology 309 (2) (2023)
Takeshi F Takahashi
Two conflicting guidelines on prostate specific antigen screening in Japan. Japanese journal of clinical oncology 53 (3) (2023)
Takeshi F Takahashi
Public health perspective on prostate-specific antigen screening: Implications of overdiagnosis and differences in health insurance systems across countries. Journal of medical screening (2022)
Takeshi F Takahashi
Two conflicting guidelines on prostate specific antigen screening in Japan. Japanese journal of clinical oncology (2022)
Takeshi F Takahashi
Comments on "Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer". International journal of cancer 151 (10) (2022)
Takeshi F Takahashi
Prostate-specific antigen screening: A kind of Russian roulette regardless of race or risk. Cancer 129 (6) (2022)
Takeshi F Takahashi
Prostate-specific antigen screening: A kind of Russian roulette regardless of race or risk. Cancer (2022)
Takeshi F Takahashi
RE: Grade Migration of Prostate Cancer in the United States During the Last Decade. Journal of the National Cancer Institute 114 (11) (2022)
Takeshi F Takahashi
Prostate-specific antigen screening: A kind of Russian roulette regardless of race or risk. Cancer 129 (6) (2022)
Takeshi F Takahashi
Prostate-specific antigen screening: A kind of Russian roulette regardless of race or risk. Cancer 129 (6) (2022)
Takeshi F Takahashi
PSA screening in high-risk groups: what are the changes in benefits and harm? British journal of cancer 127 (7) (2022)
Takeshi F Takahashi
PSA Screening: a Kind of Russian Roulette? Journal of general internal medicine 36 (9) (2021)
Takeshi F Takahashi
The golden rule: Do not do to others what you do not want done to yourself. Cancer 126 (10) (2020)
Takeshi F Takahashi
Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer? Cancer 125 (22) (2019)